EURGBP Long Idea EURGBP has been in an uptrend since late November, just about reaching the 0.86 level. Since the retest of 0.86 the price has fallen by 1%, however, it appears to have just formed support around the 0.85 area. The RSI indicator suggests that the price may rise from here as the levels are extremely oversold, (2). The target of this trade is at the recent near high of 0.86. The stop loss area for this trade is located just below the resistance level of 0.848, at 0.8474.
Coronavirus (COVID-19)
AUDCAD Sell ideaAUDCAD is currently trading around the 0.91 regions after it found support in early December at the 0.897 level. This has been an increase of the price of about 1.5%, but it has been unable to push past the resistance zone of 0.913. On the 4hr time frame, the RSI indicators are currently in overbought levels of 95.3 which indicates that the buying pressure may have faded at this level. The initial target of trade is at the 0.906 level, proceeding this is the support area of 0.897 support area.
Corona death analyses in GermanyWelcome to my Corona Death Analysis
*Note because the chart was inserted as an image, the scaling may have shifted slightly, simply scale at the right edge until the orange zero matches the zero line of the chart.
First of all, I know Corona is a delicate subject and also that I analyze the deaths here seems to work a macabre, but the fact is that the numbers are rising and this can have an impact on the German economy, this analysis serves as a complement to my DAX short analysis and is purely scientific nature.
The Dax analysis can be found here (German Only)
Let's get to the analysis:
As we can see from the chart, deaths increased rapidly between January and February, reaching a high of ca 1138.
In February, a bearish SKS formed at the high which had also already reached its target of 371 deaths.
This target line is very often reached again after the Unterstreiten in later upward movements or correction phases and serves us thus as a first "target line"
Furthermore, we can take from the chart an ABC Correct which has the following death numbers as a target.
Target 1 435
Target 2 705
Target 3 900
Target 4 1451
Target 5 1846
Here the death number of 900 is to be seen as the first strong resistance.
At 1451 I expect the end of the rising numbers for the first time, whereas 1846 deaths would be the maximum and at the latest here a trend reversal should take place.
If you liked this idea, I would be pleased about a click on the Like button ;)
If you have any questions, suggestions or a different opinion, don't be afraid to use the comment function.
Thanks a lot
Disclaimer:
Please keep in mind that this is a pure analysis and only reflects what my eye shows me ;)
This analysis is for informational purposes only and is scientific in nature.
This analysis is not based on any fundamental data!
This analysis is not an investment advice and should not be considered as a buy, sell or hold signal.
Always do your own research before investing and seek the advice of a qualified person.
I am not an investment advisor or similar and do not make any investment recommendation here.
EUR GBP Short Idea EURGBP has extended its uptrend towards the level of 0.856 which is a key level. The move to this level has lasted just under a month after EUR pairs suffered in November. It's very likely that the Uk may impose new restrictions in the coming weeks which will negatively impact the pound. If this is the case a drop in price is very likely.
GBPNZD Short Idea GBP NZD has been in a steady uptrend for about a month now, currently trading around the 1.948 levels. However, the price was unable to pass above the October 11th high of 1.97 which was a key level. The RSI indicators on the daily time frame show price are in overbought regions at the moment. The UK PM plans to hold an emergency press conference today regarding a "Plan B " for its covid response. It's very likely for the pound to suffer if the news is bearish, which it most likely will be considering the spread of the new variant.
FTSE 100 Short Idea Today at 5:30 the UK PM will be announcing a "Plan B" covid plan for the coming weeks after the emergence of the new Omnicron variant. Depending on the plan it's possible for Sterling and UK stocks to plummet if the news is bearish. The RSI indicators on the 4hr chart have just started to edge down from its overbought regions (85) indicating that there is room to go down. If we look to Europe and the economic impact that covid has had it's likely for the same to happen to the FTSE100.
Is Intel Headed for a Bull Market ? (TL;DR @ end)For the past 5 years, NASDAQ:INTC has been through quite the 'ride' of market price. For a good portion of their existence - they ran the multi-core CPU world almost entirely unchallenged. As of about 3 years ago, Advanced Micro Devices ( NASDAQ:AMD ) suddenly emerged from the mist with cheaper, greater performing chips that were idolised by the gaming and high-performance workstation community. While this was happening, Intel was far more interested in the large scale server industry, supplying various high capacity servers to various institutions such as universities and state owned research facilities. The public eye began to look down on Intel. AMD had come up neck and neck with Intel in performance and price yet Intel didn't exactly make their 'best efforts' to get ahead. Inevitably AMD surpassed them and Intel's market price fell.
Although, recently, new developments have come out of Intel (possibly consequent to the COVID pandemic). Last week, they announced the IPO of their daughter company, Mobileye. The IPO is planned for the middle of next year but this drove the stock price up slightly. Furthermore, their biggest rival, AMD has been falling behind both in the graphics card and CPU markets. The release of the 12th generation Alder Lake chips from Intel and the (stated) high performance (supposedly far better than available AMD chips) have also driven the price further up.
Intel also recently stated that they have adjusted their budget for development in desktop and laptop chips which should in theory result in the further production of even better products, even sooner.
So with an optimistic outlook on the company, the value should begin to increase and soon. If you're lucky enough to put money in now and results turn out as expected, COVID restrictions may just settle (due to Omicron not being as much of a threat) and the shortage of hardware across the industry may very well give the price that added 'leg-up'.
For investors and traders, all I would suggest is keeping your eyes peeled and thinking about the possibilities of this market dominated by only 2 companies. As usual, other opinions, facts and news are definitely welcome, so comment away!
TL;DR: Intel has been potentially pulling themselves up through these 3rd and 4th quarters. The release of 12th gen chips and the announcement of the IPO for Mobileye could all lead up to a hefty price climb. Conveniently AMD (biggest competitor) is also having a tough time and to add to this 'stroke of good luck', if COVID restrictions are eased due to the lack of intensity of the omicron, the price could climb higher.
Silver (XAG) Long Idea Silver has just seen a correction of 13.3% after the precious silver metal surpassed the key physiological level of $25. The current price is trading around $22.44 which has acted as a support area before. This area seems stable for silver, whilst there is some fundamental data dropping this week that might affect commodities, it's likely that this area will hold. The initial target for this trade is at the $24 level, the stop loss area is just below the 30th of September low - $21.67
USD CAD Long Entry USDCAD has been in a steady uptrend since the 21st of October. The price has risen by 3.22% since the price found support at the 1.23 levels. Since Friday there has been a correction of about 1.3% down to around the 1.26 area. The RSI levels on the 1hr and 4hr time frame remain very oversold which suggests that the price has room to rise from this point. The stop loss area for this trade is located at the previous resistance now turned support at 1.260. The target is the previous high at 1.274.
Stocks - Moderna Nu Pump and DumpIdea for MRNA:
- Contrarian bet
- Investors believing that Nu variant will be a boon for Moderna and vaccine stocks.
- I think the opposite. Exit for Vaccine pump and dumpers before the bear market.
- Either the Nu var is a ruse, and we dont need boosters (bearish MRNA)
- Or Nu var is resistant to all vaccines (bearish MRNA)
Either way, very cheap to fade it right now.
Long 225P Dec 17 (1.00) debit
GLHF
- DPT
GBP CAD Long idea GBPCAD has been in a steady uptrend for about a month now. In that time the price has respected the upwards trend and hasn't broken through it yet. On the 4hr chart, the Stoch-RSI indicators have just crossed in oversold territories (21), it looks like the price will increase. A scenario that might play out is that the price will fall down a little bit towards the trend line before its continuation forward. The one issue with this trade is that the price has failed to break through the 1.70 regions with any conviction, this indicates caution to me as another attempt is likely but failure to break past the resistance zone could lead to a drop in price towards the 1.684 level.
Gold Short Idea Gold has been no stranger to volatility in the last few weeks. There was a sell-off towards the levels of $1762, but now the price has rebounded towards the $1787 resistance zone. Gold's rally failed to surpass the $1800, in the short term I believe the trend is bearish. The RSI levels on the 4hr chart are overbought at 94.82. The target is the previous support level of $1770-67. The stop-loss area for this trade is located just above the recent high at $1788.
JICPT| Omicron, VIX, BTC and global marketsHello everyone. What a volatile week for investors. I just got the time to write down something after a busy week.
First of all, Fed turned to be hawkish. Taper may be accelerated according to what the Fed chair said earlier this week. In addition, He said transitory should no longer be used to describe inflation. It seems fed started to realize inflation became an issue. What feared the market is that rate hike may happen much sooner than expected.
Secondly, the first case of omicron variant of Covid was detected in U.S on Wednesday. That's another blow to the market caused by uncertainty . I see VIX continues going up after the downtrend line got violated last week. Also, the weak economic projection has been reflected in the US 10Y yield. I see it went all the way back to the old range(0.994-1.386). So far, we still need at least 2 weeks to understand the features of omicron, especially, if it can make the current vaccines less effective . If omicron intensifies the severity of the situation, fed may postpone the rate hike.
Thirdly, it's job data released on Friday. Nonfarm payrolls increased by 210K in Nov. ,well below the wall street estimation of 573K. Market shrugged off the data at the first place, then turned negative at the open. Nasdaq was down more than 300 points.
I did some research on the relationships between inflation and S&P 500. Guess what, high inflation doesn't mean weak broad market index.
inflation S&P performance
1980: 13.5% 25.8%
1979: 11.3% 12.3%
1974: 11.1% -29.7%
1981: 10.3% -9.7%
1978: 7.6% 1.1%
1977: 6.5% -11.5%
1973: 6.2% -17.4%
1982: 6.1% 14.8%
BTC is another asset I want to discuss here. After the institution joined in, its the correlation with stock market became very high. With limited liquidity, volatility is expected to be high until it reaches attractive buy zone.
Finally, I'd like to recommend a potential buying opportunity for Nasdaq around 15200 where the long-term MA meets demand zone. The long-term MA in red color has been respected well since April of last year.
Give me a like if you're with my view. Thank you for your support.
BTC Covid RallyLet's take a deep breath. This is not the move we expect. Youtubers are chaffing your brains just to catch you in fomo.... it's time to sell out due to the bigger players releasing bags onto the streets. It is only a matter of time when we will see consolidation of this movement. We are in a position to create one more breakout upwards to form a head with shoulders. But it will still be a bad signal for the coveted rally to 110k.... Big greed equals big falsehood. Be careful and draw your own conclusions from what I have plotted for you on the chart. Peace!
DocuSign Inc. and the lesson to be learnt. (TL;DR at end)When the Covid pandemic began affecting many people throughout the workplace and in their homes, companies such as NASDAQ:MSFT , Zoom and NASDAQ:GOOGL began rapidly designing software to accommodate for this very new sprouting market that nobody had ever seen before. A whole line of business dedicated to allowing people to perform their work assigned tasks from anywhere in the world or from the comfort of their couch at home. Despite the major sell-off due to the pandemic and fears of complete economic collapse in some places, a number of people and companies became considerably wealthier. A prime example that I am writing about today is DocuSign and their virtual document signing services which are in competition with NASDAQ:ADBE .
There was a massive craze over this whole digital work idea and many investors believed it was a "money-pot" for a future dominating market. Many investors began pumping money into such companies for long and short term investments. The thought behind it being, "people prefer working this way and now that they have used it, they'll never go back". This mentality obviously allowed companies like DocuSign to advance in price dramatically, because how else are you supposed to sign off a document on a desktop for instance. Despite the thought process seeming "sound", there was one major downfall.
The anticipated growth for a company like DocuSign and other competitors was astronomical. But, as Covid restrictions began to ease up slightly between the time of the announcement of the Delta variant and then Omicron, many people realised that they didn't quite enjoy working from home and/or owners of companies brought many employees back into the workplace, sales for products provided by a company like DocuSign slipped and this sent shivers through countless investors' spines as they realised how overpriced the company may have actually been in comparison to its inherent value. Needless to mention, DocuSign announcing that the "pandemic boom" in business was slowing down after they presented their slipping sales did not help in any which way, shape, nor form. This resulted in a horrific sell-off of countless stocks causing price a catastrophic price drop (especially for traders) of around $100 in Docusign and major price drops with their competitors. Consequently, Adobe had a stock price drop too as investors lost faith in their ability to maintain growth in sales (From $698 all the way through to $616 (at the time of writing)).
Now there is one major lesson to be learnt regarding this scenario and like so many before it. Deciding to become a shareholder in a company due to the potential in their industry and their presence within it alone can end horrifically. Especially when the media "hypes up" such companies resulting in horrific over-evaluations. One must perform their own investigation into the safety of such company regardless of how long you plan on holding their stock for. There is no point in putting money into a company that may not be profitable or the management consists of a number of incompetent monkeys for instance just because everybody is talking about it. You must perform your own investigation and create your own judgement on whether this company is actually worth your time. As an investor or trader, you must be careful, now as much as ever. There are countless startups having their prices floated by the media and the public's attitude towards the company which inevitably come crashing back down, even though all that could be avoided if the investor/trader actually held back until they deemed the price "acceptable or attractive" for the company.
As always, further opinions, facts and news that I may not be aware of are always welcome in the comments, it is always good to bounce ideas off of others, so comment away!
TL;DR: The work from home craze at the beginning of the pandemic ('hyped' by the media) caused many to pump money into companies that would later lose business as many returned to the workplace or their financial infrastructure was realised to be dysfunctional. One must do their own homework into companies and only pay a suitable price for the stock they're getting.
I'm Long ModernaI've been waiting for MRNA to have some stabilization during it's pullbacks -- now is the time in my opinion. For pharmaceutical companies the vaccines have been their "bread and butter" and they'll ensure they continue to innovate through a variety of new accommodations for people around the world pertaining to Covid, HIV, and anything else they can acquire funding and/or applications for.
ClearOne (CLRO) - Good M&A target, revenue growthNASDAQ:CLRO describes themselves as a global market leader enabling conferencing, collaboration, and AV streaming solutions for voice and visual communications. With businesses becoming more comfortable and familiar with remote work, ClearOne has a competitive product line (and is actively developing new products) to cater towards that market, with a product line dedicated to improving remote conferencing for those who work from home. Another benefit is that their product line also offers solutions for corporate offices, allowing themselves to be at the forefront of an enterprise's conferencing equipment.
With a market cap in the ballpack of $30 million, ClearOne is an obvious M&A target for industry competition like Cisco, Polycom, Avaya, etc. A smaller competitor, Shure (although ~3x larger in annual revenues) has filed lawsuits claiming ClearOne has been infringing on patents, with rulings constantly siding in the favor of ClearOne - an indication that competitors see them as a threat.
The stock took a big tumble in 2018 when Shure began its patent infringement claims, forcing ClearOne to suspend its dividend indefinitely. Then, the company took a bigger tumble recently as it announced a private placement offering for 2.1 million shares at a purchase price equal to $2.4925 per share, along with warrants to purchase 1.1 million shares (immediately exercisable at $2.43 per share). Insider buying since the latest crash indicates that those closest to the company see it as extremely undervalued.
According to recent filings, ClearOne has announced a product to give enterprises the ability to actively monitor their network of ClearOne products - a gateway to recurring revenue in the future - and plans on using the recently gained working-capital from the private placement to develop products that fit the changing landscape post-COVID.
We will gleam a better insight into where revenue will trend in the year-end 2021 report, and hope to see revenue show signs of real growth throughout 2022.
Full Disclosure: I am long CLRO at an entry of $1.35. I view this as a ~three-year play.
This is not financial advice and the words above reflect only my opinion. You should always do your own due diligence before making any investment.
Stocks Waiting for NFP DataStocks have attempted a meager rally, as news of the Omicron strain and Fed tightening seems to have been digested by the markets. We do have non farm payrolls data coming in at 8:30 AM EST, which is one of the biggest trading data points, so stocks are likely to hold off in anticipation of the results. This is a particularly meaningful reading, as investors look for a barometer on the faltering economy. We are seeing resistance from 4580, as this is a particulary auspicious level. We have a vacuum zone above this back to 4632. From below, we should see support from several levels below. Lows at 4504 should be considered a min lower bound for now. The Kovach OBV is very bearish, despite a rally attempt by the S&P 500, but we will need to wait for US jobs data this morning before it decides a direction.